We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VRCA market cap is 332.56M. The company's latest EPS is USD -1.5794 and P/E is -4.96.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 68k | 37k | 182k | 2.92M | 1.99M |
| Operating Income | -6.21M | -7.09M | -11.62M | -23.92M | -23M |
| Net Income | -5.93M | -6.59M | -10.99M | -24.8M | -24.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 12M | 9.03M | 5.12M |
| Operating Income | -30.08M | -40.18M | -30.91M | -21.3M | -63.22M |
| Net Income | -28.21M | -42.69M | -35.08M | -24.49M | -67M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 44.72M | 68.64M | 62.2M | 97.15M | 81.6M |
| Total Liabilities | 4.69M | 3.79M | 6.8M | 54.85M | 61.83M |
| Total Equity | 40.03M | 64.85M | 55.4M | 42.3M | 19.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 68.42M | 74.15M | 80.13M | 44.72M | 81.6M |
| Total Liabilities | 3.41M | 41.17M | 47.52M | 4.69M | 61.83M |
| Total Equity | 65.02M | 32.99M | 32.61M | 40.03M | 19.76M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.65M | -4.59M | -9.26M | -24.07M | -38.58M |
| Investing | 54.04M | -11k | -70k | -135k | -362k |
| Financing | -16.87M | 30.28M | 30.2M | 74.24M | 74.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.41M | -30.21M | -27.58M | -18.65M | -38.58M |
| Investing | 25.96M | -3.58M | -998k | 54.04M | -362k |
| Financing | 423k | 35.23M | 33.65M | -16.87M | 74.21M |
| Market Cap | 332.56M |
| Price to Earnings Ratio | -4.96 |
| Price to Sales Ratio | 64.9 |
| Price to Cash Ratio | 4.78 |
| Price to Book Ratio | 16.83 |
| Dividend Yield | - |
| Shares Outstanding | 42.42M |
| Average Volume (1 week) | 216.6k |
| Average Volume (1 Month) | 192.98k |
| 52 Week Change | 17.37% |
| 52 Week High | 7.9468 |
| 52 Week Low | 2.86 |
| Spread (Intraday) | 0.91 (11.38%) |
| Company Name | Verrica Parmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.verrica.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
